Silo Pharma, Inc. Common Stock

Go to Silo Pharma, Inc. Common Stock Website

$0.78

0.00 (0.00%)
Live
Previous Close

$0.7757

Day Range

$0 - $0

Previous Day Range

$0.7093 - $0.7794

Market Cap

$5.2 million USD

Day Vol.

0

Previous Day Vol.

344107

Currency

USD

Primary Exchange

Nasdaq

SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. I...


Community
  • 0 posts discussing
0

Watchers

1

Visitors


Recent News

Silo Pharma announced positive results from an initial study of its SP-26 ketamine extended-release implant for chronic pain and fibromyalgia, with no serious side effects observed. The company expects final safety and absorption data in March 2025.

Related tickers: SILO.

Read Full Article

Silo Pharma is making progress in developing its lead assets SPC-15 and SP-26 for the treatment of PTSD, stress-induced anxiety, and chronic pain. The company is preparing to submit an IND for SPC-15 in 2025 and is advancing animal studies for SP-26 ketamine implants.

Related tickers: SILO.

Read Full Article
Trending Tickers

Please sign in to view